Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update

Llau, Juan V.; Ferrandis, Raquel; Sierra, P.; Gómez-Luque, A.

doi:10.2147/vhrm.s7402

Cited by 10 publications

(2 citation statements)

References 110 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[869][870][871][872] Neither aspirin nor clopidogrel monotherapy needs to be discontinued before urgent orthopaedic surgery, and surgery should not be delayed in patients receiving such treatment. [872][873][874][875][876][877][878][879] Recent studies examining the effect of prior antiplatelet therapy on outcome in patients with spontaneous ICH have shown conflicting results. 880 A large, prospective trial demonstrated that antiplatelet medication at ICH onset was not associated with increased haemorrhage volumes, haemorrhage growth, or clinical outcome at 90 days.…”

Section: Allogeneic Blood Transfusion Is Associated With An Increasedmentioning

confidence: 99%

Management of severe perioperative bleeding

Kozek‐Langenecker¹,

Afshari

Albaladéjo

et al. 2013

European Journal of Anaesthesiology

738

238

View full text Add to dashboard Cite

The aims of severe perioperative bleeding management are three-fold. First, preoperative identification by anamesis and laboratory testing of those patients for whom the perioperative bleeding risk may be increased. Second, implementation of strategies for correcting preoperative anaemia and stabilisation of the macro- and microcirculations in order to optimise the patient's tolerance to bleeding. Third, targeted procoagulant interventions to reduce the amount of bleeding, morbidity, mortality and costs. The purpose of these guidelines is to provide an overview of current knowledge on the subject with an assessment of the quality of the evidence in order to allow anaesthetists throughout Europe to integrate this knowledge into daily patient care wherever possible. The Guidelines Committee of the European Society of Anaesthesiology (ESA) formed a task force with members of scientific subcommittees and individual expert members of the ESA. Electronic databases were searched without language restrictions from the year 2000 until 2012. These searches produced 20 664 abstracts. Relevant systematic reviews with meta-analyses, randomised controlled trials, cohort studies, case-control studies and cross-sectional surveys were selected. At the suggestion of the ESA Guideline Committee, the Scottish Intercollegiate Guidelines Network (SIGN) grading system was initially used to assess the level of evidence and to grade recommendations. During the process of guideline development, the official position of the ESA changed to favour the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. This report includes general recommendations as well as specific recommendations in various fields of surgical interventions. The final draft guideline was posted on the ESA website for four weeks and the link was sent to all ESA members. Comments were collated and the guidelines amended as appropriate. When the final draft was complete, the Guidelines Committee and ESA Board ratified the guidelines.

show abstract

Section: Allogeneic Blood Transfusion Is Associated With An Increasedmentioning

confidence: 99%

Management of severe perioperative bleeding

Kozek‐Langenecker¹,

Afshari

Albaladéjo

et al. 2013

European Journal of Anaesthesiology

738

238

View full text Add to dashboard Cite

show abstract

“… 9) The causes of stent thrombosis include delayed endothelialization, early cessation of antiplatelet drugs, hypersensitivity reaction of DESs to polymers, resistance to antiplatelet drugs, and lesion patterns branched lesions, and presence of risk factors such as diabetes and kidney failure. 10) 11) …”

Section: Introductionmentioning

confidence: 99%

A First-in-Man Clinical Evaluation of Sirolimus and Ascorbic Acid-Eluting Stent Systems: a Multicenter, Subject-Blinded, Randomized Study

Lim

Youn²,

Hong

et al. 2021

Korean Circ J

View full text Add to dashboard Cite

Author's summary This prospective, multi-center, randomized, comparative, and pivotal clinical study in patients with coronary artery occlusive disease was conducted to evaluate the safety and efficacy of D+Storm™ drug-eluting stent (DES), a sirolimus-eluting stent coated with polylactic acid and ascorbic acid. Our results showed that in-segment late lumen loss of D+Storm™ DES group was non-inferior to BioMatrix Flex™ DES group and the total procedural success rate of D+Storm™ DES group was 100%. In addition, the safety of the D+Storm™ DES group at 36 weeks was also demonstrated in this study.

show abstract

Coronary Artery Stents: Management in Patients Undergoing Noncardiac Surgery

Moore

Leslie

2011

AAGBI Core Topics in Anaesthesia

View full text Add to dashboard Cite

Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update

Cited by 10 publications

References 110 publications

Management of severe perioperative bleeding

Management of severe perioperative bleeding

A First-in-Man Clinical Evaluation of Sirolimus and Ascorbic Acid-Eluting Stent Systems: a Multicenter, Subject-Blinded, Randomized Study

Coronary Artery Stents: Management in Patients Undergoing Noncardiac Surgery

Contact Info

Product

Resources

About